Richmond-based pharmaceutical company Kaléo announced Tuesday five executive leadership appointments and promotions.
Joining Kaléo from Boston Scientific, where he served as the senior vice president of corporate compliance and privacy officer, Kevin Espinoza has been hired as chief compliance officer. He will oversee Kaléo’s operations. He has also previously worked with Forest Laboratories, Compliance Implementation Services, GlaxoSmithKline and Eli Lilly.
Kaléo’s previous vice president of access and trade, Allison Bridges, has been promoted as vice president and general manager of allergy and pediatrics. She will be responsible for directing channel strategy and execution. She previously worked for Donaldson, Lufkin and Jenrette, Harris Williams & Co. and Merrill Lynch.
